I believe you (and by inference bioexec) may be right here - the shift to getting Kendall & Hayes and a few others in the background eg the SAB seems to be more than just a reflection of 'the science is ready' but also an acknowledgement that we may have been promoting it in a fashion that pharma didn't connect to. This particular poster is being presented by an existing staffer so I would not expect Hayes to emerge till later this year or maybe JPM in Jan but it is all about to ramp up. Everyone on deck this month - call it orientation month - then we get to see where the strategic direction takes us.
PYC Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)